Healthcare Industry News: hernia repair device
News Release - June 5, 2007
MMDI’s Rebound HRD(TM) Receives Quality Management and CE Mark CertificationsMINNEAPOLIS, June 5, 2007 --(HSMN NewsFeed)-– Minnesota Medical Development, Inc. (MMDI) today announced that it has received ISO 13485:2003 (Quality Management) and Directive 93/42/EEC (CE Mark) certifications for the design, manufacture and distribution of its Rebound HRD(TM) (hernia repair device) in European Union member countries.
The Rebound HRD(TM) is a self-expanding Nitinol framed/surgical mesh medical device designed for the laparoscopic repair of both inguinal and ventral hernias. The super-elastic Nitinol frame allows the device to be folded and inserted laparoscopically. Once deployed, the device fully unfurls or “rebounds” back to its original shape – ready for quick and easy placement over the hernia defect. The Rebound HRD(TM) conforms to the anatomy while providing stability; eliminating the need for anchoring, which in turn, minimizes patient post-op discomfort and the risk of nerve/blood vessel injury. Although the Rebound HRD(TM) is ideally suited for laparoscopic surgery it may also be placed via an open incisional approach using the same dissection and positioning methods described for the laparoscopic technique.
“Our employees have worked very hard to achieve this milestone with the Rebound HRD(TM) and we are looking forward to our global rollout of the device. The Rebound HRD(TM) adds a new dimension to prior surgical hernia repair techniques in terms of delivery, placement and overall performance,” said MMDI Chief Marketing Officer, Steve Nuss.
In 2006, The Society of Laparoendoscopic Surgeons (SLS) recognized the Rebound HRD(TM) as one of the “2006 Innovations of the Year.” The SLS acknowledged the Rebound HRD(TM) as part of its 15th International Congress and Endo Expo 2006, held September 6-9 in Boston, Massachusetts.
Additional information can be obtained by contacting Steve Nuss, Chief Marketing Officer at 763-354-7105 or firstname.lastname@example.org. You may also visit our website at: www.2mdinc.com
The Rebound HRD(TM) is currently pending FDA 510k approval.
The SLS does not endorse or approve any products.
MMDI was established in 2001 and is based in Plymouth, Minnesota. Located in the heart of Minnesota’s “Medical Alley”, MMDI has access to some of the world’s finest medical product development, manufacturing and marketing resources. The Company’s primary objective is to identify, develop, patent and manufacture unique medical devices that provide significant clinical benefits and market opportunities.
Issuer of this News Release is solely responsible for its
Please address inquiries directly to the issuing company.